Cargando…

Respiratory syncytial virus pneumonia in a LDLT recipient transplanted for COVID 19 precipitated ACLF: Treated with ribavirin and IVIg

Detalles Bibliográficos
Autores principales:	Kapoor, Sorabh, Parikh, Pathik, Waghmare, Vishal, Kotadiya, Jitendra, Parikh, Tejas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055020/ http://dx.doi.org/10.1016/j.ijsu.2022.106440

Ejemplares similares

A Modified MELD Model for Chinese Pre-ACLF and ACLF Patients and It Reveals Poor Prognosis in Pre-ACLF Patients
por: Xia, Qi, et al.
Publicado: (2013)

Autoimmune Hepatitis Triggered by Treatment With Pegylated Interferon α-2a and Ribavirin for Chronic Hepatitis C
por: Rathi, Chetan, et al.
Publicado: (2015)

RIBAVIRIN AND RESPIRATORY SYNCYTIAL VIRUS
Publicado: (1986)

1600. An Optimal Respiratory Syncytial Virus (RSV) Treatment in Lung Transplant Recipients: Oral Ribavirin, Inhaled Ribavirin, or Conservative Approach
por: Permpalung, Nitipong, et al.
Publicado: (2018)

Prognostic Value of Acute-On-Chronic Liver Failure (ACLF) Score in Critically Ill Patients with Cirrhosis and ACLF
por: Lin, Xinran, et al.
Publicado: (2020)

Restarting LDLT During COVID-19: Early Results After Restructuring
por: Jha, Sandeep K., et al.
Publicado: (2021)

Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients
por: Seeßle, Jessica, et al.
Publicado: (2020)

Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?
por: Görgülü, Esra, et al.
Publicado: (2022)

Comparing CLIF-C ACLF, CLIF-C ACLF(lactate), and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience
por: Kuo, Chao-Cheng, et al.
Publicado: (2021)

Impact of Preexisting Circulating Effector T cells on the Outcome of ABO-Incompatible Adult LDLT
por: Egawa, Hiroto, et al.
Publicado: (2008)

The analgesic efficacy of continuous transversus abdominis plane block in renal transplant recipients
por: Parikh, Beena Kandarp, et al.
Publicado: (2015)

Comment on experience with LDLT in patients with hepatocellular carcinoma and portal vein tumor thrombosis postdownstaging
por: Akbulut, Sami, et al.
Publicado: (2020)

Knowledge of Herbal Medicines – Is a Reverse Bridge Course an Urgent Necessity?
por: Parikh, Pathik
Publicado: (2022)

Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF
por: Blasi, Annabel, et al.
Publicado: (2019)

Connection between HPS and ACLF: a solution of chaos?
por: Maruyama, Hitoshi, et al.
Publicado: (2021)

The Role of Pretransplant Infections in Pediatric Receiving LDLT in Indonesia: A 7-y Retrospective Study
por: Alatas, Fatima Safira, et al.
Publicado: (2023)

Respiratory Syncytial Virus Infection Morbidity in the Elderly: Time for Repurposing of Ribavirin?
por: de Zwart, Auke E S, et al.
Publicado: (2020)

Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient With Ribavirin
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

A new model for identification of HBV-related pre-ACLF
por: Jalan, Rajiv, et al.
Publicado: (2022)

Egyptian protocol for living donor liver transplantation (LDLT) during SARS-CoV-2 pandemic
por: Abd Elbaset, Hany Said, et al.
Publicado: (2021)

Is a Preservation Solution for Living Donor Liver Transplantation Needed? Adding a New Chapter in LDLT!
por: Dogar, Abdul Wahab, et al.
Publicado: (2022)

2795. Clinical and Economic Impact of a Ribavirin Intervention Program in Hematopoietic Cell and Solid-organ Transplant Recipients with Respiratory Syncytial Virus Infection
por: Leonard, Emily, et al.
Publicado: (2019)

Changes in Serum Bone Metabolism Markers after Living Donor Liver Transplantation (LDLT) and Their Association with Fracture Occurrences
por: Kuo, Shu-Jui, et al.
Publicado: (2023)

Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
por: Weiss, Emmanuel, et al.
Publicado: (2021)

Successful Outcome of Human Metapneumovirus (hMPV) Pneumonia in a Lung Transplant Recipient Treated With Intravenous Ribavirin
por: Raza, Kashif, et al.
Publicado: (2007)

Supplemental Oxygen–Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus
por: Waghmare, Alpana, et al.
Publicado: (2017)

Treatment of scleromyxedema with IVIg
por: Moser, David W, et al.
Publicado: (2012)

Cascade plasmapheresis (CP) as a preconditioning regime in ABO-incompatible live related donor liver transplants (ABOi-LDLT)
por: Tiwari, Aseem Kumar, et al.
Publicado: (2014)

Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease
por: Wang, Zhouping, et al.
Publicado: (2020)

Successful Treatment of Autoimmune Hemolytic Anemia with Steroid, IVIg, and Plasmapheresis in a Haploidentical Transplant Recipient
por: Uz, Burak, et al.
Publicado: (2012)

Iatrogenic Arteriovenous Fistula Following Femoral Access Precipitating High-Output Heart Failure
por: Zilinyi, Robert S., et al.
Publicado: (2021)

PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF
por: Li, Jiang, et al.
Publicado: (2022)

Streptococcus Pneumoniae-Related Hemophagocytic Lymphohistiocytosis Treated with Intravenous Immunoglobulin (IVIG) and Steroids
por: Dumancas, Carissa Y., et al.
Publicado: (2018)

A Comparative Study of IVIG versus IVIG with IV Methylprednisolone in Guillain–Barre Syndrome
por: Bhattiprolu, Rahi Kiran, et al.
Publicado: (2020)

Prediction and Management of Small-for-size Syndrome in Living Donor Liver Transplantation: Methodology of the ILTS-iLDLT-LTSI Consensus Conference
por: Rela, Mohamed, et al.
Publicado: (2023)

The analgesic efficacy of ultrasound-guided transversus abdominis plane block for retroperitoneoscopic donor nephrectomy: A randomized controlled study
por: Parikh, Beena K., et al.
Publicado: (2013)

Respiratory Syncytial Virus Pneumonia Treated with Lower-Dose Palivizumab in a Heart Transplant Recipient
por: Grodin, J. L., et al.
Publicado: (2012)

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease
por: Kim, Yae-Jean, et al.
Publicado: (2014)

Cooling down VITT with IVIG
por: Lentz, Steven R.
Publicado: (2021)

923. Respiratory Syncytial and Parainfluenza Virus Infection Increase the Risk of Cytomegalovirus Reactivation in Allogeneic Hematopoietic Cell Transplant Recipients
por: Xie, Hu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d9a2m304gd6m2an69nusreaneh